FLGT Q4 2018 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q4 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$6M+32.7% YoY

Gross Profit

$3M51.3% margin

Operating Income

-$1M-18.1% margin

Net Income

-$935,000-16.5% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+1.0%

Cash Flow

Operating Cash Flow

$778,000

Free Cash Flow

$655,000

Stock-Based Comp.

$598,000

Balance Sheet

Total Assets

$55M

Total Liabilities

$3M

Stockholders' Equity

$52M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$4M	+32.7%
Gross Profit	$3M	$2M	+67.9%
Operating Income	-$1M	-$2M	+50.3%
Net Income	-$935,000	-$2M	+42.4%